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INTRODUCTION
The development of cardiovascular disease depends mainly
on the presence of risk factors (RFs). Over 200 cardiovascu-
lar RFs have been described (Gotto and Pownal, 2003), with
the most important being age, sex, smoking habit, diabetes
mellitus, elevated blood pressure (BP), high level of low-
density lipoprotein cholesterol (LDL-C), low level of high-
density lipoprotein cholesterol (HDL-C), and unfavourable
family history (Gotto and Pownal, 2003; Smith et al., 2004;
Smith and Milani, 2004). Obesity and sedentary lifestyle are
additional and supporting RFs (Gotto and Pownal, 2003;
Smith et al., 2004), whereas recently demonstrated RFs in-
clude elevated triglyceride (TG) levels and various inflam-
matory markers; e.g., C-reactive protein (CRP) (Smith et
al., 2004).
The total cardiovascular disease risk is estimated not only
by the number and degree of RFs (Smith et al., 2004), but
also by their interaction (Gotto and Pownal, 2003; Venere-
anu, 2006), as RFs are often combined and act synergisti-
cally (Gotto and Pownal, 2003). Metabolic RFs have re-
cently been identified from cardiovascular RFs and pooled
in a metabolic syndrome that includes abdominal obesity,
abnormal glucose tolerance, elevated blood pressure, in-
creased TG levels, and decreased HDL-C levels (Gotto and
Pownal, 2003).
Many RFs share the same pathogenetic mechanism and are
commonly present at the same time; e.g., obesity associated
with arterial hypertension and dyslipidaemia, dyslipidaemia
and arterial hypertension, and summarising of RFs in a
metabolic syndrome setting (Erhardt and Betterige, 2004;
Weycker et al., 2007). More than 50% of patients with arte-
rial hypertension have dyslipidaemia and increased body
mass index (BMI) (Weycker et al.,2007). Patients with obe-
sity have higher systolic and diastolic blood pressure (SBP
and DBP) and higher levels of blood glucose, total choles-
terol, and TGs (De Lusignan et al., 2006); thus, the “harm-
fulness” of RFs is determined by their unfavourable influ-
ence on the endothelium, which induces endothelial
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Various cardiovascular risk factors (RFs) were determined in 773 out-patients (mean age 55.8 ±
14.5 years). Male individuals had a larger waist circumference (WC) than did female patients
(99.1 ± 13.6 cm vs 93.3 ± 15.2 cm), higher diastolic blood pressure (DBP) (83.6 ± 9.6 mmHg vs
81.8 ± 9.6 mmHg), and higher levels of blood glucose (5.73 ± 1.4 mmol/L vs 5.49 ± 1.3 mmol/L)
and triglycerides (TG) (1.89 ± 1.3 mmol/L vs 1.60 ± 1.0 mmol/L), but lower levels of total choles-
terol (TC) (5.54 ± 1.2 mmol/L vs 5.79 ± 1.2 mmol/L) and high-density lipoprotein cholesterol
(HDL-C) (1.21 ± 0.4 mmol/L vs 1.44 ± 0.4 mmol/L). Compared with the younger age group (i.e.,
males, < 7 years; females, < 65 years), patients in the older age group had a larger WC (98.4 ±
14.2 cm vs 92.8 ± 15.1 cm), higher systolic blood pressure (SBP) (144.2 ± 19.2 mmHg vs 131.6 ±
18.5 mmHg), higher DBP (84.5 ± 8.8 mmHg vs 80.9 ± 9.8 mmHg), higher blood glucose level
(5.74 ± 1.3 mmol/L vs 5.46 ± 1.3 mmol/L), and higher low-density lipoprotein cholesterol level
(LDL-C) (3.68 ± 1.0 mmol/L vs 3.52 ± 1.0 mmol/L), but lower HDL-C level (1.3 ± 0.4 mmol/L vs
1.41 ± 0.4 mmol/L). Age was significantly correlated with all RFs, with the exception of the level of
C-reactive protein. In conclusion, analysis of cardiovascular RFs in different age subgroups of
both sexes clearly showed individual peculiarities of risk profile. This conclusion challenges the
usual way of risk calculation using “universal” markers like adiposity or dyslipidemia in all popula-
tion. The new approach requires individual attention depending on sex and age also in manage-
ment of risk.
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dysfunction as the main pathogenetic mechanism of athero-
sclerosis.
Studies of mutual correlations between RFs have shown
that increased BMI and waist circumference (WC) correlate
with glycaemia, TG levels, and BP; however, an inverse
correlation has been reported between these two RFs and
HDL-C levels (Rezende et al., 2006). Japanese studies have
revealed a more pronounced mutual correlation in females,
particularly between TG and CRP levels (Oda et al., 2006).
The total cardiovascular risk increase in females is the result
of increased RF correlation rates. RF correlation is deter-
mined by the following data: a decrease in obesity results in
lower SBP and DBP and elevated HDL-C levels (Inzucchi
et al., 2007), and the regression of atherosclerosis is more
pronounced as a result of a concomitant reduction in LDL-C
levels and increase in HDL-C levels (Aiviram, 2007).
Therefore, attempts to minimise cardiovascular RFs should
always be multifactorial, and as many RFs as possible
should be influenced concomitantly (Gotto and Pownal,
2003).
The successful prevention of cardiovascular disease is based
on the identification of RFs and their effective correction.
One of the great achievements over recent decades in the
quest to reduce the mortality associated with cardiovascular
disease in the USA has been the active and successful fight
against unfavourable RFs (Ford et al., 2007). Almost half
(44%) of the reduction in the cardiovascular disease-related
mortality is associated with changes in RFs, whereas the re-
maining half is associated with the successful treatment of
cardiovascular problems (e.g., re-vascularisation and treat-
ment of heart failure and acute coronary syndrome).
Over the past 40 years in the USA, total cholesterol (TC)
levels and BP have decreased in patients with obesity.
These patients also smoke less; however, the prevalence of
diabetes mellitus has increased (Gregg et al., 2005). A large
international study (Yusuf et al., 2004) showed that tradi-
tional RFs (e.g., dyslipidaemia, smoking, arterial hyperten-
sion (AH), and abdominal obesity) promote the develop-
ment of myocardial infarction; thus, prevention of
cardiovascular disease should be based on a simple princi-
ple: the elimination of RFs. It should be noted that this pre-
vious study also showed that the prevalence of RFs and
their correlation with myocardial infarction are different in
various countries and ethnic groups. The marked variation
in the prevalence of atherosclerosis and cardiovascular dis-
ease in different countries may be explained by the variabil-
ity in the prevalence of specific RFs in these countries.
It would be ideal to elaborate individual risk reduction mod-
els for each patient or patient group (Vinereanu, 2006). The
differential access to various patient groups, based on the
levels of RFs and their correlation, is important in reducing
the risk of cardiovascular disease.
Of particular importance is the examination of the total car-
diovascular risk as it pertains to sex and age. It is well
known that the development of cardiovascular disease in
pre-menopausal women occurs ten years later than in men;
however, after menopause, the incidence of the disease is
similar between men and women. The significance of the
data regarding the variation of different cardiovascular RFs
according to sex remains controversial. For example, higher
CRP levels have been reported in females (Arena et al.,
2006), and previous studies have debated the prevalence of
obesity in females compared with males (De Lusignan et
al., 2006; Rezende et al., 2006). It has also been suggested
that AH and diabetes have a greater impact in females
(Yusuf et al., 2004). In the presence of several RFs, the risk
of coronary heart disease (CHD) is seven-fold greater in
males and five-fold greater in females than the risk in per-
sons with no cardiovascular RFs (Gotto et al., 2003).
The effect of obesity differs between males and females. In-
creased BMI is a RF for stroke in both sexes; however, in-
creased WC is only a RF in males (Hu et al., 2007). The de-
gree of obesity also has a different impact in males and
females. In younger patients (< 55 years), a BMI > 21
kg/m2 in females and > 25 kg/m2 in males is considered a
cardiovascular RF; in older patients (> 55 years), the risk
BMI threshold is > 30 kg/m2. Available data suggest that
dyslipidaemia is an independent RF only in males; in fe-
males, the risk may be determined by more extensive oxida-
tive stress rather than the levels of lipids (Vassalle et al.,
2007).
An examination of the correlation of other RFs with age re-
vealed that only the correlation with TG levels should be
considered. No significant correlation was found between
age and obesity, HDL-C, SBP, or DBP (Agheishahsavari et
al., 2006). Significantly higher LDL-C, CRP, and oxidized
LDL-C levels were found in females older than 56. In con-
trast, TG and HDL-C levels do not vary with age. A direct
correlation between age and CRP and oxidized LDL-C lev-
els has been reported in females.
The prevalence of RFs in various regions and countries
throughout the world shows considerable variation, thereby
explaining the different mortality rates from cardiovascular
diseases worldwide. The situation is very unfavourable in
Latvia, as the cardiovascular mortality rate is one of the
highest in Europe. The prevalence of RFs and their mutual
correlations, especially regarding sex and age, are poorly
studied in Latvia.
Taking into consideration the great variation in cardiovascu-
lar RFs and mortality rate among different countries and re-
gions, as well as the controversial data regarding the corre-
lation and interaction between RFs, particularly for sex and
age, the aim of our study was to characterise the main car-
diovascular RFs and their correlation with sex and age in
the Latvian population.
MATERIALS AND METHODS
To collect data on the prevalence of cardiovascular RFs, we
examined patients who attended their primary care setting
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(PCS) for a planned visit to deal with any health-related
problem. A total of 773 persons examined by their doctor in
30 PCSs over a period of four days were asked to provide
data about their health status (objective investigations).
Blood samples were collected from all patients. PCSs were
distributed throughout all regions of Latvia, including Rîga.
All persons were included by voluntary consent. The exclu-
sion criteria were as follows: age < 18 years and > 75 years,
renal disease with chronic renal failure, thyroid gland dis-
ease with hyper- or hypo-function, liver disease with
liver-cell insufficiency, oncological disease with dissemina-
tion and possible influence on metabolism, and signs of
acute inflammatory process. All patients gave their in-
formed consent to the protocol, which was approved by the
local Medical Ethics Committee of Latvian Institute of Car-
diology of University of Latvia for Medical Research.
Physical examination (height, weight, and BP and WC mea-
surement) was carried out using standardised and certified
measuring devices. The statistical software SPSS was used
for the storage and processing of obtained data.
The following parameters and cardiovascular RFs were
evaluated separately in males and females, as well in differ-
ent age groups (males, < 55 and ≥ 55 years; females, < 65
and ≥ 65 years): body mass, height, WC, BMI, SBP, DBP,
heart rate (HR), blood glucose level, and levels of TC,
LDL-C, HDL-C, TG, and CRP. We also compared the RFs
in a younger age group (males, < 55 years; females, < 65
years) with those in an older age group (males, ≥ 55 years;
females, ≥ 65 years). Fasting concentrations of lipids and
glucose were analysed using standard methods. After test-
ing the normality of date distribution, statistical differences
between the above mentioned groups were assessed using
t-test. Data were recorded as the mean ± SD, and two-tailed
values of P < 0.05 were considered significant. Pearson’s
correlation coefficient (PCC) was used to assess the correla-
tion of RFs with sex and age.
RESULTS
Among all patients questioned, 71.3% were female, 21.6%
were smokers, 52.7% had pre-existing AH, and 10.9% had
previously diagnosed diabetes. The patient group was char-
acterised by the following parameters (± standard devia-
tions (SD)): mean age, 55.6 ± 14.5 years; BMI, 28.98 ±
5.61 kg/m2; WC, 94.9 ± 14.9 cm; SBP, 136.3 ± 19.8
mmHg; DBP, 82.3 ± 9.6 mmHg; HR, 73.8 ± 8.1 beats per
minute; blood glucose level, 5.56 ± 1.33 mmol/L; TC, 5.72
± 1.22 mmol/L; LDL, C 3.58 ± 1.03 mmol/L; HDL-C, 1.38
± 0.38 mmol/L; TG, 1.69 ± 1.15 mmol/L; CRP, 3.87 ± 8.50
mg/L.
Tables 1 and 2 list the main differences and level of signifi-
cance (P) of patient characteristics and cardiovascular RFs
in subgroups organised according to sex and age.
The results listed in Table 1 reveal higher values of WC,
DBP, and levels of blood glucose and TG in males, and
lower values of TC and HDL-C. Compared with the youn-
ger age group, the older group had higher values of WC,
SBP, DBP, blood glucose level, and LDL-C, and lower val-
ues of HDL-C. We observed no significant difference in the
levels of TC and TG between older and younger individu-
als, and no differences in the levels of CRP and HR be-
tween sexes and age groups.
Separate analysis of the two age subgroups according to sex
(Table 2) revealed that older males (≥ 55 years) had shorter
height, but larger WC and SBP when compared with youn-
ger males. We observed no differences for the other param-
eters. Analysis of the two age subgroups in females re-
T a b l e 1
VARIABILITY IN CARDIOVASCULAR RISK FACTORS ACCORDING TO SEX AND AGE (MEAN ± SD)
Parameter Male Female P Younger age group Older age group P
Body mass 88.2 ± 15.8 78.7 ± 15.8 0.000 80.9 ± 17.3 82.2 ± 14.5 0.297
Height 176.3 ± 7.3 164.2 ± 6.0 0.000 167.9 ± 8.5 167.3 ± 8.4 0.364
WC 99.13 ± 13.6 93.3 ± 15.2 0.000 92.8 ± 15.1 98.4 ± 14.2 0.000
BMI 28.37 ± 4.69 29.22 ± 5.92 0.055 28.73 ± 5.96 29.37 ± 4.95 0.126
SBP 138.0 ± 18.6 135.7 ± 20.2 0.134 131.6 ± 18.5 144.2 ± 19.3 0.000
DBP 83.6 ± 9.6 81.8 ± 9.6 0.018 80.9 ± 9.8 84.5 ± 8.8 0.000
HR 78.4 ± 9.3 73.6 ± 7.5 0.216 73.4 ± 7.9 74.5 ± 8.4 0.057
Glucose 5.73 ± 1.45 5.49 ± 1.27 0.021 5.46 ± 1.31 5.74 ± 1.34 0.004
TC 5.54 ± 1.19 5.79 ± 1.22 0.009 5.67 ± 1.24 5.80 ± 1.17 0.153
LDL-C 3.49 ± 0.95 3.61 ± 1.05 0.146 3.52 ± 1.04 3.68 ± 0.98 0.046
HDL-C 1.21 ± 0.36 1.44 ± 0.36 0.000 1.41 ± 0.38 1.33 ± 0.37 0.006
TG 1.89 ± 1.33 1.60 ± 1.05 0.001 1.64 ± 1.19 1.76 ± 1.07 0.170
CRP 4.65 ± 10.72 3.56 ± 7.41 0.106 3.73 ± 9.85 4.12 ± 5.61 0.536
Younger age group = males, < 55 years; females, < 65 years. Older age group = males ≥ 55 years; females, ≥ 65 years. Body mass (kg); height (cm); WC,
waist circumference (cm); BMI, body mass index (kg/m2); SBP and DBP, systolic and diastolic blood pressure (mm Hg); HR, heart rate (beats per min); glu-
cose (mmolog /L); TC, total cholesterol (mmol/L); LDL-C, low-density lipoprotein cholesterol (mmol/L); HDL-C, high-density lipoprotein cholesterol
(mmol/L); TG, triglycerides (mmol/L); CRP, C-reactive protein (mg/L)
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vealed the presence of shorter height in the older subgroup.
We also found a larger WC and higher SBP, DBP, and HR
in females than in males. Compared with the older female
subgroup, the younger male subgroup showed larger WC,
higher DBP, and lower TC and HDL-C levels. When corre-
lating age with other parameters in the general study group
and by sex and age, we took into consideration the marked
differences in RFs between males and females and among
the various age subgroups (Table 3).
Age correlated with all the investigated parameters except
for CRP. We found an inverse correlation between height
and HDL-C levels. The correlations observed for females
were similar to those found in the general study group. A
comparison of all subgroups revealed that the highest PCC
occurred between age and other RFs in females younger
than 65 years. In older males and females, age did not corre-
late with any of the RFs under investigation. These results
indicate that the impact of the RFs was heightened with in-
creasing age in females younger than 65 years, and partly in
males younger than 55 years. It should be noted that above
these thresholds, age did not influence RFs. The strongest
correlations (i.e., the highest PCC values) between age and
WC, SBP, TC, and LDL-C levels were found in the youn-
ger female subgroup. An inverse correlation was found be-
tween these parameters and increasing age. Blood glucose
level correlated with age only in the younger age subgroups.
We found an increase in WC, BMI, SBP, DBP, blood glu-
cose level, TC, LDL-C, and TG with increasing age,
whereas HDL-C levels decreased with increasing age. We
observed no increase in these parameters in males older
than 55 years and in females older than 65 years; we even
found a negative PCC value. These results suggest that WC,
DBP, blood glucose, LDL-C, and TG values do not increase
with increasing age; in fact, these parameters tended to de-
crease with age.
DISCUSSION
Our observations reveal great differences in the characteris-
tics of the cardiovascular RFs investigated in patients of
both sexes. Higher values of WC, DBP, blood glucose
level, and TG were found in males than in females, whereas
TC and HDL-C levels were lower in males. We also found
different values for DBP, blood glucose, TC, and TG ac-
cording to sex. We suggest that the generally accepted dif-
ference between male and female WC values (14 cm) is too
large: our Latvian data suggest it could be as little as 5–6
cm. It is interesting that of the two obesity parameters (WC
and BMI), only WC increased with increasing age. A de-
crease in the degree of obesity starting at 64 years of age
has been described in the literature (De Lusignan et al.,
2006). There is no justification to set different normal val-
ues for DBP, blood glucose, TC, and TG in males and fe-
males; however, the differences detected in our study war-
rant further investigation. Our data show that in the general
study group, DBP is lower in females than in males; how-
ever, DBP did not increase with increasing age in males, as
it did in females.
Our evaluation of changes in lipid profiles revealed that fe-
males had higher TC, HDL-C, and TG levels than did
males; however, we did not find any marked differences be-
tween sexes regarding LDL-C levels. More pronounced
lipid changes (with the exception of HDL-C) have been re-
T a b l e 2
CHANGES IN ANTHROPOMETRIC AND PHYSICAL PARAMETERS, AND CARDIOVASCULAR RISK FACTORS IN SUBGROUPS ORGANISED
ACCORDING TO SEX AND AGE (MEAN ± SD)
Parameter Male P Female P P* P**
< 55 ≥ 55 < 65 ≥ 65
Age 41.0 ± 10.0 66.1 ± 7.1 0.000 48.9 ± 11.2 71.5 ± 4.3 0.000 0.000 0.000
Body mass 90.1 ± 15.9 86.7 ± 15.6 0.114 78.6 ± 16.9 78.9 ± 13.4 0.802 0.000 0.000
Height 179.1 ± 6.9 174.0 ± 6.7 0.000 165.0 ± 6.1 162.5 ± 5.6 0.000 0.000 0.000
WC 96.7 ± 12.9 101.0 ± 13.9 0.020 91.8 ± 15.4 96.5 ± 14.2 0.001 0.004 0.006
BMI 28.08 ± 4.65 28.61 ± 4.73 0.403 28.91 ± 6.25 29.93 ± 5.06 0.061 0.215 0.024
SBP 133.0 ± 17.4 142.0 ± 18.7 0.000 131.2 ± 18.8 145.7 ± 19.6 0.000 0.388 0.109
DBP 82.8 ± 9.9 84.2 ± 9.4 0.296 80.4 ± 9.8 84.8 ± 8.4 0.000 0.030 0.558
HR 74.3 ± 9.0 74.4 ± 9.6 0.914 73.1 ± 7.5 74.6 ± 7.5 0.039 0.191 0.888
Glucose 5.58 ± 1.36 5.86 ± 1.51 0.156 5.42 ± 1.30 5.65 ± 1.21 0.052 0.279 0.191
TC 5.45 ± 1.22 5.61 ± 1.17 0.328 5.73 ± 1.25 5.94 ± 1.15 0.062 0.049 0.018
LDL-C 3.37 ± 0.91 3.58 ± 0.98 0.103 3.56 ± 1.07 3.74 ± 0.99 0.063 0.121 0.193
HDL-C 1.22 ± 0.36 1.21 ± 0.37 0.775 1.45 ± 0.37 1.41 ± 0.35 0.286 0.000 0.000
TG 2.01 ± 1.66 1.80 ± 0.97 0.247 1.55 ± 1.01 1.72 ± 1.13 0.063 0.001 0.564
CRP 4.41 ± 14.72 4.85 ± 5.84 0.764 3.55 ± 8.15 3.59 ± 5.40 0.956 0.439 0.058
P* males < 55 years vs females < 65 years; P** males ≥ 55 years vs females ≥ 65 years; body mass (kg); height (cm); WC, waist circumference (cm); BMI,
body mass index (kg/m2); SBP and DBP, systolic and diastolic blood pressure (mm Hg); HR, heart rate (beats per min); glucose (mmol/L); TC, total choles-
terol (mmol/L); LDL-C, low-density lipoprotein cholesterol (mmol/L); HDL-C, high-density lipoprotein cholesterol (mmol/L); TG, triglycerides (mmol/L);
CRP, C-reactive protein (mg/L)
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ported previously in females (Aghaeishahvari et al., 2006).
Levels of LDL-C and HDL-C were higher and lower, re-
spectively, in the older age subgroups; however, levels of
TG were similar in all age groups. The literature reports
(Aghaeishahvari et al., 2006) that TG is the only lipid to
correlate with age, yet we found correlations between age
and TC, LDL-C, and TG levels, and an inverse correlation
between age and HDL-C levels in the general study group.
We found no such correlations in the male subgroup. In-
creased values of SBP, DBP, blood glucose, and LDL-C
were found in older age subgroups, as well as decreased
levels of HDL-C. In contrast, the levels of TC and TG re-
mained unchanged with age. A stronger correlation among
RFs was found previously in females (Oda et al., 2006).
The evaluation of RFs enables the identification of patient
subgroups with the most unfavourable RF development
with increasing age. Prevention of the development of these
RFs could be a highly effective strategy in the prevention of
cardiovascular disease.
We found an increase in WC, SBP, and blood glucose lev-
els with increasing age, independently of sex; however, in-
creased BMI, TC, LDL-C, and TG were observed with in-
creasing age exclusively in females, along with decreasing
HDL-C. In the younger age subgroups, we found increasing
WC, BMI, SBP, DBP, blood glucose, TC, LDL-C, and TG
with increasing age in both sexes, and decreasing HDL-C;
in contrast, these parameters did not change with age in the
older age subgroups.
Our data suggest that the effective prevention of cardiovas-
cular risk increase is more reasonable in younger age groups
and in females. Although young females have a lower car-
diovascular risk in general, primary and secondary preven-
tion measures would be most effective in this population.
The most promising and possibly most effective RF correc-
tions would pertain to WC, BMI, SB, and DBP in younger
age groups of both sexes, as well as correction of lipid lev-
els in younger females. Relatively high risks of dyslipid-
aemia and AH have been reported in the literature in youn-
ger patients. The correlation of age with blood glucose
level, WC, SBP, and DBP exclusively in younger patient
groups may indicate the necessity of a more active correc-
tion of metabolic syndrome in younger patients. It should
also be noted that a higher diabetes risk has been reported in
younger individuals, especially in females (Yusuf et al.,
2004).
T a b l e 3
CORRELATION INDEX (PCI) FOR AGE AND OTHER PARAMETERS IN THE GENERAL STUDY GROUP, IN MALES AND FEMALES, AND IN
THE VARIOUS AGE SUBGROUPS
Parameter GG Younger
group
Older group M F Male Female



































































































































































































































































GG, general study group; younger age group = males, < 55 years and females, < 65 years; older age group = males, ≥ 55 years and females, ≥ 65 years; body
mass (kg); height (cm); WC, waist circumference (cm); BMI, body mass index (kg/m2); SBP and DBP, systolic and diastolic blood pressure (mm Hg); HR,
heart rate (beats per min.); glucose (mmol/L); TC, total cholesterol (mmol/L); LDL-C, low-density lipoprotein cholesterol (mmol/L); HDL-C, high-density li-
poprotein cholesterol (mmol/L); TG, triglycerides (mmol/L); CRP, C-reactive protein (mg/L)
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In conclusion, analysis of cardiovascular risk factors in dif-
ferent age subgroups of both sexes clearly showed individ-
ual peculiarities of risk profile. This conclusion challenges
the usual way of risk calculation using “universal” markers
like adiposity or dyslipidemia in all population. The new
approach requires individual attention depending on sex and
age also in management of risk.
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KARDIOVASKULÂRIE RISKA FAKTORI UN TO KORELÂCIJA AR PACIENTU DZIMUMU UN VECUMU LATVIJÂ
773 ambulatoriem pacientiem (ar vidçjo vecumu 55,8 ± 14,5 gadi) tika analizçti daþâdi sirds asinsvadu slimîbu (SAS) riska faktori (RF). No
izmeklçtajiem pacientiem, vîrieðiem bija lielâks vçdera apkârtmçrs (VA) kâ sievietçm (99,1 ± 13,6 cm pret 93,3 ± 15,2 cm), augstâks
diastoliskais asinsspiediens (DAS) (83,6 ± 9,6 mmHG pret 81,8 ± 9,6 mmHG), augstâks glikozes (5,73 ± 1,4 mmol/L pret 5,49 ± 1,3
mmol/L) un triglicerîdu (TG) (1,89 ± 1,3 mmol/L pret 1,60 ± 1,0 mmol/L) lîmenis, bet zemâks kopçjâ holesterîna (KH) (5,54 ± 1,2 mmol/L
pret 5,79 ± 1,2 mmol/L) un augsta blîvuma lipoproteînu (ABLH) (1,21 ± 0,4 pret 1,44 ± 0,4 mmol/L) lîmenis. Salîdzinot jaunâko pacientu
grupu (t.i. vîrieði < 55 gadiem un sievietes <65 gadiem) ar vecâko pacientu grupu, vecâkajiem bija lielâks VA (98,4 ± 14,2 cm pret 92,8 ±
15,1 cm), augstâks sistoliskais asinsspiediens (SAS) (144,2 ± 19,2 mmHg pret 131,6 ± 18,5 mmHg), augstâks DAS (84,5 ± 8,8 mmHg pret
80,9 ± 9,8 mmHg), augstâks glikozes lîmenis (5,74 ± 1,3 mmol/L pret 5,46 ± 1,3 mmol/L) un augstâks zema blîvuma lipoproteînu
holesterîna (3,68 ± 1,0 mmol/L pret 3,52 ± 1,0 mmol/L) lîmenis, bet zemâks ABLH lîmenis (1,3 ± 0,4 mmol/L pret 1,41 ± 0,4 mmol/L).
Vecums ticami korelçja ar visiem riska faktoriem izòemot C-reaktîvo olbaltumu. Pçtîjums parâdîja to, ka katrai vecuma un abu dzimuma
grupâm ir atðíirîgi dominçjoðie riska faktori, un to ietekmes novçrðanai mazinâðanai nepiecieðamas atðíirîgas pieejas.
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